Darina Ocadlikova
Istituto Di Ematologia Via Massarenti 9
Bologna, 40138, Italy
Bologna, 40138, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Noncanonical NF-κB signaling in dendritic cells is required for ATP-driven indoleamine 2,3-dioxygenase 1 induction through P2Y11 receptor.
Journal: Journal of leukocyte biology
Published: May 31, 2024
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells.
Journal: Frontiers in immunology
Published: February 15, 2024
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study.
Journal: British journal of haematology
Published: January 14, 2023
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters.
Journal: Frontiers in immunology
Published: October 29, 2021
Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 06, 2021
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia.
Journal: Blood advances
Published: April 05, 2021
A Screening of Antineoplastic Drugs for Acute Myeloid Leukemia Reveals Contrasting Immunogenic Effects of Etoposide and Fludarabine.
Journal: International journal of molecular sciences
Published: September 08, 2020
Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia.
Journal: Frontiers in oncology
Published: July 02, 2019
Flow cytometry T cell profiling in a recent-onset narcoleptic type 1 child: a case report.
Journal: Sleep medicine
Published: May 23, 2019
Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
Journal: Stem cell research & therapy
Published: July 11, 2018
Last Updated: 09/26/2026